
Financial Data and Key Metrics Changes - For the full year 2024, the company achieved $442 million in revenue, a gross profit of $111.5 million, and an operating income of $48 million, reflecting a year-over-year revenue increase of nearly 40% [12][30] - Net income for 2024 was $73.2 million, compared to $84.4 million in the previous year, indicating a decrease in net income [31] - The gross profit margin slightly decreased from $112.1 million in 2023 to $111.5 million in 2024 [34] Business Line Data and Key Metrics Changes - The Low-Enriched Uranium (LEU) segment generated $349.9 million in revenue, an increase of $80.9 million compared to 2023, driven by growth in uranium and Separative Work Unit (SWU) revenue [31] - The Technical Solutions segment reported $92.1 million in revenue, an increase of $40.9 million compared to 2023, with a gross profit of $17.6 million, improving by $10.6 million year-over-year [34] Market Data and Key Metrics Changes - The company’s total backlog reached $3.7 billion as of year-end, extending to 2040, with the LEU segment backlog approximately $2.8 billion [35] - The Technical Solutions segment backlog was approximately $0.9 billion, including funded amounts and unexercised options related to the HALEU operation contract [37] Company Strategy and Development Direction - The company aims to restore America's ability to enrich uranium, focusing on domestic production to meet energy and national security needs [9][19] - Recent contract awards from the Department of Energy (DOE) for HALEU enrichment and deconversion are expected to support the restart of American LEU enrichment, reducing dependence on foreign sources [16][17] - A $60 million investment was announced to resume centrifuge manufacturing and expand capacity at the Oak Ridge facility, reinforcing the company's first-mover advantage [23][38] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting bipartisan support for nuclear energy and the importance of restoring domestic uranium enrichment capabilities [43][44] - The company is positioned to capitalize on the growing demand for enriched uranium, especially with the upcoming ban on enriched uranium imports from Russia starting in 2028 [24][28] Other Important Information - The company successfully raised $402.5 million through convertible senior notes, enhancing liquidity for strategic investments [37][39] - The company has begun exploring opportunities for investment tax credits, receiving approval for $62.4 million in credit allocations for its manufacturing facility [41][42] Q&A Session Summary Question: Follow-up on DOE contracts and task orders - Management indicated that while there is forward movement on task orders, they would not speculate on timing [52][56] Question: Details on the $60 million investment - The investment is aimed at readiness and preparation for upcoming task orders, allowing the company to react quickly when they are issued [56][58] Question: TENEX licenses and uranium sales - Management confirmed positive traction with TENEX licenses but could not disclose specific numbers; the high uranium sales in Q4 were due to market opportunities rather than inventory liquidation [65][68] Question: Expectations for 2025 - While management does not provide guidance, they remain opportunistic regarding uranium sales and have a sizable inventory to capitalize on market conditions [76][78] Question: Investment tax credit details - The investment tax credit can be realized over a four-year period, contingent on meeting specific conditions [82][84]